Commentary: Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial
Front Neurol
.
2019 Jul 5:10:667.
doi: 10.3389/fneur.2019.00667.
eCollection 2019.
Authors
Friedrich Leblhuber
1
,
Kostja Steiner
1
,
Burkhard Schuetz
2
,
Dietmar Fuchs
3
Affiliations
1
Department of Gerontology, Neuromed Campus, Kepler University Clinic, Linz, Austria.
2
Biovis Diagnostik MVZ GmbH, Limburg, Germany.
3
Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
PMID:
31333558
PMCID:
PMC6624731
DOI:
10.3389/fneur.2019.00667
No abstract available
Keywords:
Alzheimer's dementia (AD); TYM test; biomarkers; inflammation; probiotic supplementation.
Publication types
Comment